JOHNSON & JOHNSON 10-K

Item 5. Market for registrant’s common equity, related stockholder matters and issuer purchases of equity securities As of February 4, 2026, there were 108,358 record holders of common stock of the Company. Additional information called for by this item is incorporated herein by reference to the following sections of this Report: Note 16 “Common Stock, Stock Option Plans and Stock Compensation Agreements” of the Notes to Consolidated Financial Statements included in Item 8; and Item 12 “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters – Equity Compensation Plan Information.” Issuer purchases of equity securities The following table provides information with respect to common stock purchases by the Company during the fiscal fourth quarter of 2025. Common stock purchases on the open market are made as part of a systematic plan to meet the needs of the Company’s compensation programs. The repurchases below also include the stock-for-stock option exercises that settled in the fiscal fourth quarter. Fiscal Period Total Number of Shares Purchased (1) Avg. Price Paid Per Share Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs September 29, 2025 through October 26, 2025 3,806,577 192.15 — — October 27, 2025 through November 23, 2025 1,690,213 193.54 — — November 24, 2025 through December 28, 2025 4,225,966 204.81 — — Total 9,722,756 — (1) During the fiscal fourth quarter of 2025, the Company repurchased an aggregate of 9,722,756 shares of Johnson & Johnson Common Stock in open-market transactions, all of which were purchased as part of a systematic plan to meet the needs of the Company’s compensation programs. Item 6. Reserved 2025 Annual Report 21